Natriclo (Sodium Chloride)

Sodium chloride dissociates into sodium and chloride ions after infusion. The increased extracellular sodium raises osmolarity, drawing water into the vascular space and expanding plasma volume. Restoring chloride supports acid‑base balance, while both ions help maintain essential electrolyte gradients for normal cellular function.

The dose of Natriclo is determined by the prescribing clinician based on the patient’s clinical condition, fluid losses, and electrolyte status. Healthcare professionals calculate the required volume and rate of infusion to achieve the desired therapeutic effect, following institutional protocols.

Safety data for Natriclo in pregnancy and lactation are limited, and the product does not have a specific pregnancy category. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Natriclo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and import documentation.

Natriclo is a standard isotonic saline (0.9% NaCl) similar to other normal saline solutions used for volume expansion. Compared with hypertonic or balanced electrolyte solutions, Natriclo provides a simple sodium‑chloride composition without additional buffers, making it suitable for rapid volume replacement but less tailored for specific acid‑base corrections.

Natriclo should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from direct sunlight, excessive heat, and moisture. Do not freeze the product, and inspect the container for any signs of damage before use.

Natriclo is administered intravenously using aseptic technique. The solution is infused through a suitable vein, typically via a peripheral or central line, at a rate prescribed by the clinician. Infusion sets should be compatible with the solution, and the administration site should be monitored for signs of irritation or phlebitis.

Serious risks include severe allergic reactions such as anaphylaxis, significant electrolyte imbalances (e.g., hypernatremia or hyperchloremia) when administered in excess, and fluid overload leading to pulmonary edema or heart failure in susceptible patients. Prompt recognition and medical intervention are essential if these events occur.

Natriclo should be avoided in individuals with known hypersensitivity to sodium chloride, those with uncontrolled congestive heart failure or severe fluid overload, and patients where rapid volume expansion could exacerbate existing cardiac or renal conditions. Clinical judgment is required to assess suitability for each patient.